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Laminin and collagen IV subunit distribution in normal
and neoplastic tissues of colorectum and breast
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Summary To invade and metastasize, carcinomas must penetrate or lose their epithelial basement membrane (EBM), and then penetrate
basement membranes (BMs) surrounding blood vessels, lymphatics, nerves and muscle cells. Knowledge of the composition of different BMs
is necessary, so that appropriate antibodies and DNA probes are used to analyse these events. Laminin and type IV collagen are the principal
BM components. However, recent studies show these two proteins exist in various isoforms, each of which is a heterotrimer of different
subunit polypeptides. In this study, we analysed the distribution of laminin subunits, ax1 (lam), ax2(lam), f1 (lam), P2(lam) and yl (lam), and
collagen IV subunits, cr1 (IV), a3(IV), ca4(IV) and c5(IV), in normal and neoplastic tissues of colorectum and breast. Subunits ca1 (IV), ca1 (lam),
fl(lam) and yl(lam) were detected in all BMs, while the distribution of a3(IV), ax4(IV), a5(IV) and ax2(lam) was much more restricted. In
carcinomas, EBM staining for all subunits was invariably discontinuous or absent, consistent with the presence of complete EBM breaks. Use
of antibody to cr1 (lam) selectively stained the EBMs of carcinomas. Strong vascular staining for ac1 (lam), 1l (lam), yl (lam) and a1 (IV)
suggests an abundance of BM proteins in vessel walls, which may aid tumour cell attachment before vascular invasion. Within carcinomas,
vascular BM staining for 12(lam) was clearly weaker than in normal tissues, which may reflect incomplete maturation of these vessels.
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Following the report that epithelial basement membrane (EBM)
breaks are associated with the malignant phenotype in epithelial
tumours (Barsky et al, 1983), there has been intense interest in the
diagnostic and prognostic significance of these breaks, and the
literature on this subject is extensive [reviewed by D'Ardenne
(1989) and Bosman (1994)]. Such studies on human colorectal
(Forster et al, 1986; Havenith et al, 1988; Hewitt et al, 1991) and
breast cancer (Albrechtsen et al, 1981; Barsky et al, 1983) have
shown marked EBM deficiencies. These studies have generally
involved immunocytochemical staining for either of the major
basement membrane proteins, laminin or collagen IV.
Recently, it has been found that laminin and collagen-IV exist in
a variety of isoforms with different subunit compositions.
However, practically the entire literature on basement membranes
in cancer is based on immunocytochemical studies using anti-
bodies that do not discriminate between these different subunits.
The classical collagen IV molecule is composed of two crl(IV)
subunits and one oc2(IV) subunit, which together form a triple
helix. Novel collagen IV subunits have been found more recently,
and these include the oc3(IV), cx4(IV) and cx5(IV) subunits
(Tryggvason et al, 1993). The laminin molecule is also a
heterotrimer ofdifferent subunits (Engvall et al, 1990). In classical
laminin, the subunits were originally designated A, B I and B2, but
have recently been renamed crl, Pi and yl respectively (Burgeson
et al, 1994). Subunits M and S, which were described in novel
isoforms of laminin, have been renamed oc2 and P2 respectively.
All isoforms of laminin appear to contain one oc chain, one A chain
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and one ychain. To avoid confusion with the collagen IV subunits,
the laminin subunit names will be given the suffix '(lam)' in this
article.
In a recent in situ hybridization study by Pyke et al (1994),
mRNA for the novel y2(lam) subunit was found to be specifically
overexpressed by actively invading neoplastic cells in both
colorectal and breast carcinomas. This finding may have prog-
nostic significance and underlines the need for detailed studies on
the expression of different laminin and collagen IV subunits in
cancer. Studying the expression of these subunits in basement
membranes around normal structures, such as blood vessels and
nerves, may also offer clues to understanding the invasive behav-
iour of cancers, as there is accumulating evidence that basement
membranes regulate the differentiation and behaviour of adjacent
cells (Klein et al, 1988; Van Den Hooff, 1989; Sorokin et al, 1990).
We have therefore carried out a descriptive study on normal and
neoplastic tissues of colorectum and breast to document for the
first time the distribution of the following subunits ofcollagen IV:
crl(IV), oc3(IV), cr4(IV), cr5(IV); and laminin: crl(lam), cr2(lam),
, 1(lam), P2(lam) and yl(lam).
MATERIALS AND METHODS
Antibodies
Anti-collagen IV antibodies used were rabbit polyclonal antiserum
raised against human placental collagen-IV and monoclonal clone
1042 (Euro-Path Bude, UK), monoclonal CIV22 (Dako, Bucks,
UK) and monoclonal antibodies MAb AI 0, MAb A2, MAb 85 and
MAb A7 (gifts from Dr AF Michael). The polyclonal and mono-
clonals, clone 1042 and CIV22, are non-subunit specific. MAb A7
recognizes the cx5(IV) subunit, which is the same molecule as the
Alport antigen (Ding et al, 1994). Monoclonals to the cx2(IV)
subunit have been difficult to produce, and none were available
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Table 1 Antibodies used in this study
Antigen Antibody Reference
Laminin PcAb
al(lam) 4C7 Sanes et al (1990)
ci2(lam) 5H2 Sanes et al (1990)
fl (lam) 4E10 Sanes et al (1990)
,2(lam) C4 Sanes et al (1990)
yl(lam) 2E8 Sanes et al (1990)
Collagen IV PcAb
Collagen IV Clone 1042 Havenith et al (1987)
Collagen IV CIV 22 Odermatt et al (1984)
et1 (IV) MAb Al0 Ding et al (1994)
a3 (IV) MAb A2 Ding et al (1994)
a4 (IV) MAb 85 Ding et al (1994)
a5 (IV) MAb A7 Ding et al (1994)
Monoclonal antibody clone designations are given. PcAb, polyclonal
antibody.
to us. Anti-laminin antibodies employed were rabbit polyclonal
antiserum raised against laminin from mouse EHS sarcoma
(Euro-Path), monoclonals 4C7 and 5H2 (Telios Pharmaceuticals,
San Diego, CA, USA), monoclonals 4E10 and 2E8 (Chemicon
International, Temencula, CA, USA) and monoclonal C4 (a gift
from DrJ R Sanes). Antibody specificities and references are given
in Table 1. Secondary antibodies included horseradish peroxidase-
conjugated swine anti-rabbit and rabbit anti-mouse antibodies
(Dako), diluted 1:50 and 1:I00 respectively.
Tissue processing and immunocytochemistry
Samples of normal and neoplastic human colorectal tissue were
obtained from bowel specimens received by the Department of
Histopathology, Queen's Medical Centre, Nottingham. These
included five samples of normal mucosa, five adenomas (four
tubular, one villous) and ten moderately differentiated adenocarci-
nomas. Samples of breast tissue were obtained from specimens
received by the Department of Histopathology, City Hospital,
Nottingham. All the breast carcinomas studied had been entered
into the Nottingham Tenovus Breast Cancer study. Tumour type
was classified according to accepted criteria (Ellis et al, 1992). The
samples included normal breast tissue in five cases, fibroadenoma
in two cases and eight cases of breast carcinoma (three cases of
carcinoma of no special type, one tubular carcinoma, one tubular
mixed carcinoma, one atypical medullary carcinoma and two
lobular carcinomas). Ductal carcinoma in situ (DCIS) was present
in five sections ofcarcinoma, and lobular carcinoma in situ (LCIS)
was present in one case. To obtain sections from healing wounds,
tissue samples were taken from three mastectomy specimens in
which lumpectomy had been performed 23-25 days previously.
Samples of normal human kidney were obtained at post mortem.
All tissue samples were quenched in isopentane precooled in
liquid nitrogen and stored at -70°C until required for sectioning.
Cryostat sections of 4-5 ,um were cut, air dried and then fixed in
95% ethanol for 5 min at 4°C. Those sections to be stained with
MAb85 and MAb A7 specifically were then denatured (presumed to
expose buried epitopes) by incubation in 6M urea, 0.lM glycine HCl,
pH 3.5 for I h at 4°C (Yoshioka et al, 1985). All sections were then
rinsed three times with phosphate-buffered saline (PBS) at room
temperature, before staining using a two-step indirect immuno-
peroxidase method as described previously (Hewitt et al, 1992).
Sections of normal human kidney were used as a tissue control
to demonstrate the reliability of antibody preparations. To test the
specificity of staining reactions, sections of colorectal and breast
tissue were stained, but with the omission ofthe primary antibody.
RESULTS
Control sections of human kidney
Glomerular BM staining was seen for all antibodies, except those
specific for al(IV), l(lam) and ox2(lam), which instead showed
prominent mesangial matrix staining (Figure 1). Both proximal and
distal tubular BMs were stained by all antibodies against al(lam),
Pl(lam) and yl(lam), and by anti-al(IV). Only the distal tubular
BMs stained for x3(IV) and x4(IV), and no other novel laminin
and collagen-IV subunits were detected in tubular BMs. These
results are generally consistent with previous reports (Kleppel et al,
1989; Sanes et al, 1990) and confirm that all antibodies used in this
study were working effectively for immunocytochemistry.
EBM
In normal and neoplastic colorectal tissues (see Table 2 and
Figure 2), al(lam), Pl(lam) and yl(lam) were detected in the
EBMs, as was al(IV). EBM staining was generally continuous in
normal mucosa and adenomas, but discontinuous in all the carci-
nomas observed (Figure 3). There was little evidence of novel
subunit expression [i.e. subunits x3(IV), ox4 (IV), a5(IV), a2(lam)
or 12(lam)] in EBMs of either normal or neoplastic colorectal
tissues. The only examples were (1) weak staining for a3(IV)
subunit beneath the surface epithelium of normal mucosa; (2)
weak staining for a2(lam) at the bases of glands in normal
mucosa; and (3) focal a2(lam) staining in adenomas.
Table 2 Immunostaining of EBMs in normal and neoplastic tissues of
colorectum and breast
Colorectal Breast
Antigen NM A C N F DCIS NST L
Laminin (PcAb) 2+ 2+ -/3+ 2+ + 2+ -1+ -I+
cl(lam) 2+ 2+ -/3+ 3+ 3+ 3+ -/2+
a2(lam) (+)b (2+)' - - + + -
,13 (lam) 3+ 2+ -/3+ 3+ 3+ 3+ -/2+ -I+
,B2(lam) - (+)' - 2+ 2+ 2+ -
yl(lam) 3+ 2+ -/2+ 3+ 3+ 3+ -/2+ -I+
Collagen IV (PcAb) 3+ 3+ -/3+ 3+ 3+ 3+ -/2+ -I+
Collagen IV (clone 1042) 2+ 2+ -/3+ 3+ 2+ 3+ -/2+
Collagen IV (CIV 22) 2+ 2+ -/3+ 3+ 2+ 2+ -/+
al (IV) + + -/+ 2+ 2+ + -/+
a3 (IV) (+)s
a4(IV)
a5 (IV) - - - - +
Not all cases of breast carcinoma are represented, but scores for tubular and
atypical medullary carcinomas followed the same pattern as shown for the
NST carcinomas. The tubular mixed carcinomas only showed weak staining
with the collagen-IV polyclonal and monoclonals, 1042 and CIV22. The LCIS
showed a similar pattern to the cases of DCIS. Scoring of staining intensity:
3+, strong; 2+, moderate; +, weak; - absent; -/3+, strong but discontinuous.
NM, normal colorectal mucosa; A, colorectal adenoma; C, colorectal
carcinoma; N, normal breast tissue; F, fibroadenoma; NST, carcinomas of no
special type; L, lobular carcinoma. b gland base;s surface epithelium;', focal.
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Figure 1 Kidney control sections stained for various antibodies to collagen IV. Staining with polyclonal anti-collagen IV (A) detects antigen in the glomerular BM
(short arrow), Bowman's capsule (long arrow) and the renal tubule BM (arrowheads). The monoclonal clone 1042 (B) gave a similar pattern. The anti-al (IV)
monoclonal (C) also stained Bowman's capsule and the tubular BM, but stained mesangial matrix (arrowheads) rather than glomerular BM. Antibodies against
a3(IV) and a4(IV) subunits, (D) and (E) respectively, stained the glomerular BM, Bowman's capsule and BMs of the distal (arrow) but not proximal tubules.
Staining for the a5(1V) subunit (F) was only seen in the glomerular BM and Bowman's capsule
In normal breast tissue (see Table 2), there was EBM staining for
oxl(lam), PI(lam), yl(lam) and al(IV), as well as for 32(lam)
unlike colorectal tissues. In fibroadenomas and in situ carcinoma,
the EBM stained additionally for o2(lam), and fibroadenomas also
showed weak EBM staining for the c5(IV) subunit. Where EBM
staining was present in these lesions, it was continuous, with the
exception of the strong but patchy staining for o2(lam) in the
lobular carcinoma in situ (LCIS). By contrast, invasive breast
carcinomas invariably showed either discontinuous or absent EBM
staining. Discontinuous staining was seen for oxl(lam), fl(lam)
and yl(lam), and for ox (IV). No EBM staining for o2(lam),
,2(lam), a3(IV), x4(IV) or oc5(IV) was seen in any invasive breast
carcinoma, with the exception of one atypical medullary carci-
noma, which showed weak patchy staining for the P2(lam).
Blood vessels, lymphatics and nerves
The capillaries of normal colorectal mucosa and adenomas stained
for ocl(lam), f31(lam), f2(lam), yl(lam) and cxI(IV). The capillaries
ofnormal breasttissue and fibroadenomas also stained forthese anti-
gens and, in addition, stained for o2(lam) and o5(IV). Capillaries of
both colorectal and breast carcinomas gave similar staining results to
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Figure 2 Immunostaining of normal human colorectal tissues. The clone 1042 anti-type IV collagen monoclonal stains a variety of structures in normal mucosa
(A), including the EBM (large arrow) and cells with a dendritic-type morphology (small arrows). Staining for the x3(IV) subunit (B) is restricted to the EBM
beneath the luminal surface epithelium (large arrow) and non-specifically stained macrophages (small arrows). Staining for the Alport antigen (C) is seen in
nerves (arrow), but not blood vessels of the submucosa (arrowhead). In (D), staining for l2(lam) is seen in both nerves (arrow) and blood vessels (arrowhead)
of the submucosa, but not large lymphatic vessels (ly). Staining patterns for yl (lam) (E) and 31 (lam) (F) differ in that arterial smooth muscle only stains for
y1 (lam) (black arrowhead). Staining for both antigens is seen in the BM surrounding ganglia of the myenteric plexus (white arrows) and around individual
smooth muscle cells of the muscularis propria
corresponding normal tissues, with the exception that staining
for P2(lam) was weak or absent in carcinomas (see Table 3 and
Figure 4). Sections taken from three different healing wounds
(23-25 days old) were also immunostained. In areas of wound
healing, the capillaries showed weak P2(lam) staining, but staining
was stronger in capillaries ofthe adjacent normal tissue (Figure 4).
Larger blood vessels, seen most often in normal colorectal
tissues, showed staining for ocl(lam), DI(lam), P2(lam), yl(lam)
and uxl(IV). One prominent feature was that in arteries, the smooth
muscle layer showed a selective absence of staining for the
1(lam) subunit (Figure 2F).
Larger lymphatic channels in the colorectal submucosa stained
for olI(IV), PI (lam) and yl(lam), but unlike blood vessels they did
not stain for cxl(lam) or 32(lam) (Figure 2 D). Lymphatic capil-
laries were not examined here, as these vessels were too difficult
to identify in our cryostat sections.
Autonomic nerves and ganglia seen in colorectal tissues stained
with all antibodies used in this study, except antibodies to the
oc3(IV) and ct4(IV) subunits. Unlike any other component of
colorectal tissues, autonomic nerves and ganglia did stain for the
oc5(IV) subunit.
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Figure 3 Immunostaining of sections of a colonic carcinoma with polyclonal
anti-laminin antibody. In the photomicrograph (A), continuous staining of the
EBM is seen within the tumour (arrows), but no staining is seen at the
invasive edge (arrowheads). These features are emphasized in the
schematic diagram (B), in which connective tissue is represented in white,
neoplastic cell islands and glands in grey, and basement membranes that
envelop the neoplastic cell areas are shown in black
Smooth muscle and stromal myofibroblasts
Smooth muscle cells of muscularis mucosae and propria in the
colorectum showed moderate or strong staining for all antigens
studied (Figure 2), with the exception of oc2(lam), a3(IV), ax4(IV)
and ax5(IV), for which there was no staining.
Cells with dendritic-type morphology having multiple long thin
processes were also observed between the glands in normal
colorectal mucosa (Figure 2A). These cells were most obvious in
sections stained with antibody to ax2(lam), as this did not stain
neighbouring structures such as EBM, blood vessels or muscular
layers of the bowel wall. Preliminary ultrastructural studies
suggest that these unusual cells with multiple processes are myofi-
broblast-like (T Gray and RE Hewitt, unpublished observations).
In both colorectal and breast carcinomas, stromal myofibro-
blasts showed weak or absent staining for ocl(lam) (see Figure 5),
despite moderately strong staining for 1(lam) and yl(lam)
subunits and for ocl(IV). In sections stained for ocl(lam), the
EBMs are therefore especially prominent.
DISCUSSION
There have been many immunocytochemical studies on basement
membrane staining in colorectal and breast neoplasms. However,
Table 3 Capillary immunostaining in normal and neoplastic tissues of
colorectum and breast
Colorectal Breast
Antigen NM A C N F C
Laminin (PcAb) 2+ 3+ 3+ + + 2+
xl(lam) 2+ 3+ 2+ 3+ 3+ 3+
a2(lam) - - - + + -
1l(lam) 2+ 3+ 3+ 3+ 3+ 3+
P2(lam) + 2+ -/+ 3+ 2+ +
yl (lam) 3+ 3+ 3+ 3+ 3+ 3+
Collagen IV (PcAb) 3+ 3+ 3+ 2+ 2+ 3+
Collagen IV (clone 1042) 3+ 3+ 3+ 3+ 2+ 3+
Collagen IV (CIV 22) 3+ 3+ 3+ 2+ 2+ 2+
al(IV) 2+ 2+ 2+ 2+ 2+ 2+
a3(IV) - - - - - -
a4 (IV) -
a5 (IV) - - - + 2+
NM, normal mucosa; N, normal breast tissue; A, adenoma; F, fibroadenoma;
C, carcinoma.
with only a very few exceptions, the anti-laminin and anti-collagen
IV antibodies used in such studies have been non-subunit specific.
Now that subunit-specific antibodies and DNA probes are avail-
able, it is possible to obtain more detailed and meaningful infor-
mation about the interactions between tumour cells, their EBMs
and other basement membranes they encounter. For example, in a
previous in situ hybridization study using a cDNA probe for
oxl(IV) (Hewitt et al, 1992), we found that the hybridization signal
was entirely localized to blood vessels. This raised the possibility
that the collagen IV demonstrated in the EBMs by immunocyto-
chemistry might consist of novel collagen IV isoforms. However,
in the light of our present results this seems less likely, as the
EBMs of colorectal carcinomas stained for the xl(IV) subunit of
classical collagen IV, but not for a3(IV), a4(IV) and cx5(IV).
Pyke et al (1994) have recently reported an in situ hybridization
study using probes for oxl(lam), [l(lam) and yl(lam) to analyse
colonic cancers. In the 16 colon carcinomas studied, the hybridiza-
tion signal for these three probes was weak and was consistently
localized both to stromal cells with fibroblast-like morphology and
to the endothelial cells of small vessels. These findings are consis-
tent with the results of the present study, in that xl(lam), [l(lam)
and yl(lam) were all detected in blood vessel walls by immuno-
cytochemistry. Presumably, endothelial cells contribute to the
synthesis of laminin deposited in the blood vessel wall. Pyke et al
(1994) never found expression of c I(lam), [ 1(lam) and yl(lam) in
neoplastic cells of colon cancers, which may indicate that EBM
laminin in these tumours is derived mainly or entirely from
stromal fibroblasts. As mentioned previously, Pyke et al (1994) did
find a marked increase in y2(lam) expression in neoplastic cells at
the invasive edge of colorectal cancers. We did not find evidence
for any similar increases in expression of laminin or collagen-IV
subunits, although y2(lam) was not examined in this study.
EBM staining patterns
In non-malignant tissues of both colorectum and breast tissue, we
have found obvious EBM staining for subunits of classical laminin
[ocl(lam), [l(lam) and yl(lam)] and for the ocl(IV) subunit of
classical collagen IV. Staining for all these antigens was patchy in
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Figure 4 Vascular staining patterns in carcinomas and in healing wounds. Widespread vascular staining (arrows) was seen in sections of colonic carcinoma
(A), tubular mixed breast carcinoma (C) and a 23-day-old healing breast wound (E), when stained with antibodies against classical collagen-IV and laminin
subunits [cl1042 monoclonal, anti-al(lam) and anti-yl(lam) respectively]. However, with antibody to P2(lam), there was no vascular staining in either the colonic
carcinoma (B) or the breast carcinoma (D). Similarly, for the breast wound (F), there was little evidence of vascular staining for ,B2(lam) in the healing wound
itself (hw), but there was vascular staining in the adjacent normal tissue
carcinomas, which is consistent with the fact that EBMs are discon-
tinuous in these tumours. The myofibroblasts in breast andcolorectal
carcinomas showed staining for PI(lam) and yl(lam), but not obvi-
ously for xtl(lam). Consequently, staining with antibody to (cl(lam)
demonstrated the EBMs most specifically, with the least background
stromal staining. Use of antibody to oxl(lam) should therefore be
advantageous for studies on EBM staining patterns in cancer.
In both colorectal and breast tissues, there was a lack of EBM
staining for novel ox3(IV) and oc4(IV) subunits. Weak staining for
the ux5(IV) subunit was seen in the EBM of breast fibroadenomas,
but in no other tissue. For both colorectal and breast tissues,
o2(lam) showed a sporadic staining pattern. While EBM staining
for the antigen was generally weak or absent, intense focal staining
was seen in an area ofLCIS, and moderately strong focal staining
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Figure 5 Immunostaining of stromal cells in carcinomas. Serial sections of a colonic adenocarcinoma were stained for axl(lam) (A) and 31 (lam) (B). In the same
way, serial sections of lobular breast carcinoma were stained for adl(lam) (C) and 131 (lam) (D). For both types of carcinoma, stromal components were stained
for 131 (lam), but not (xl(lam). In the lobular carcinoma there was no evidence of EBM staining, except in an area of in situ carcinoma or LCIS (L)
was seen in colorectal adenomas. The significance of this finding
is unclear at present.
An interesting difference was observed between non-malignant
tissues of colorectum and breast. While P2(lam) was not detected
in the EBM ofnon-malignant colorectal tissues, it was consistently
detected in EBMs of normal breast tissues, including normal
breast, fibroadenomas and both ductal and lobular carcinoma in
situ. This difference in the composition of EBM in normal tissues
of breast and colorectum may be the result of different synthetic
capabilities of epithelial cells at these two sites. Equally, it may
influence the type of differentiation shown by epithelia in these
two locations.
While ,32(lam) staining was present in EBMs of non-malignant
breast tissues, it was almost completely absent from the EBMs of
breast carcinomas. This suggests that in tumours of the breast,
levels of f2(lam) staining may be inversely related to invasive
activity. It is possible that loss of the subunit facilitates the inva-
sive process, but its loss may also be secondary to invasive
activity. In contrast, staining for ox2(lam) was not seen in the
EBMs of either normal breast tissues or frankly invasive cancers,
but was seen in fibroadenomas and in situ carcinomas of the
breast. Further studies on the distribution of 32(lam) and aX2(lam)
in breast neoplasia seem worthwhile, as they may help in the
differential diagnosis ofbenign and malignant lesions.
Otherevidence that theP2(lam) contentofEBMs deserves further
investigation comes from a report by Sollberg et al (1992), who
found the EBM of nodular basal cell carcinomas does stain for
[2(lam), while the EBM of normal epidermis does not. Taken
together, all this evidence suggests that theP2(lam) content ofEBMs
varies greatly, depending on the character ofthe adjacent cells.
Blood vessel staining
Vascular staining patterns in breast and colorectal tissues were
similar and showed prominent staining for all the subunits of
classical laminin, and for the oal (IV) subunit ofclassical collagen IV.
This abundance ofBMproteins may facilitate tumourcell attachment
to the walls of blood vessels, which may in turn lead to dissolution
ofthe vessel wall and penetration into the vascular lumen, according
to the 'three-step' hypothesis ofinvasion (Liotta et al, 1983).
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While vascular staining for P2(1am) was prominent in non-
malignant tissues of breast and colorectum, it was often weak or
absent in the vessels within carcinomas. Interestingly, we also
found that the newly formed and poorly differentiated blood
vessels of healing wounds showed deficient 12(lam) staining.
There is abundant evidence that blood vessels ofcarcinomas show
incomplete differentiation, as they are often dilated with irregular
endothelial linings, scanty perivascular connective tissues and
tortuous, disorganized courses (Willis, 1973; Denekamp, 1983).
Furthermore, in an extensive study on human tumours, Lindgren
(1945) found that vascular architecture was most abnormal in the
less well-differentiated malignant tumours. It is therefore possible
that the low level of vascular staining for P2(lam) in carcinomas
is a result of the incomplete differentiation of the tumour blood
vessels.
Although vascular staining in colorectal and breast tissues
showed generally similar patterns, a difference was seen with
respect to staining for the oc5(IV) subunit. In colorectal tissues,
only the autonomic nerves and ganglia stained for this antigen.
However, in normal breast tissue there was weak staining ofcapil-
laries and larger blood vessels, and moderately strong vascular
staining was seen in fibroadenomas. This suggests a difference in
BM composition between blood vessels of normal colorectal and
breast tissues.
We previously used an ax(IV) subunit cDNA probe for an in
situ hybridization (ISH) study on colorectal carcinomas (Hewitt et
al, 1992) and found a high level of mRNA expression in some
tumour blood vessels, but no detectable expression in any other
tumour component. This pattern of expression seems consistent
with the present immunocytochemical results, which suggest that
the ot1 (IV) subunit is more abundant in the walls of tumour blood
vessels than in the EBM or any other tumour component. It may be
relevant that blood vessels in some cancers produce high levels of
the protease inhibitor, plasminogen activator inhibitor 1 (PAI-1),
and it has been hypothesized that this is part of a protective
response to prevent proteases produced within the tumour from
degrading the tumour's own vascular connective tissue stroma
(Kristensen et al, 1990). The high levels ofcollagen IV production
in blood vessels of colorectal cancer (Hewitt et al, 1992) may be
part ofthe same protective response.
The significance of differences in BM composition
The varied laminin and collagen-IV subunit composition of
different BMs raises the interesting question of why there should
be a biological need for this level of complexity. One reason may
be that different subunits impart different physical properties to
BMs, such as differences in permeability. For example, in the
kidney, the high volume unidirectional transfer of fluid may be
facilitated by the high levels of novel collagen IV subunits in the
glomerular BMs (Kleppel et al, 1989). Another reason for the
complexity may be that different subunits may have important
regulatory effects on the biological activities of adjacent cells.
Supporting evidence comes from the fact that f2(lam), unlike
01(lam), contains sequences selective for the attachment of
motoneurones (Sanes et al, 1990). As P2(lam) is abundant in
synaptic BM, this may explain why the regenerating axons in
denervated muscle preferentially form neuromuscularjunctions at
the original synaptic sites (Hunter et al, 1989). P2(lam) therefore
appears to have very specific effects on the behaviour of at least
one cell type. The selective loss of f2(1am) from epithelial and
vascular BMs in cancers, observed in the present study, may
therefore have important effects on the behaviour of adjacent
neoplastic and endothelial cells.
CONCLUSION
The findings of this study show that the o2(lam) subunit and the
novel chains of collagen-IV [a3 (IV), o4 (IV) and ax5(IV)] show
limited expression in normal and neoplastic tissues of colorectum
and breast. In contrast, the subunits ofclassical laminin [(Xl (lam),
31(lam) and yl(lam)] and the ax(IV) chain are very widely distrib-
uted in the basement membranes of these tissues. To our knowl-
edge, this is the first immunocytochemical study to document the
distribution of any of the subunits of laminin and collagen IV in
either colorectal or breast cancer. It is hoped that the information
presented here will provide a useful reference point for future
investigations.
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